Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy

Saved in:
Bibliographic Details
Published in:Molecular Biomedicine
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1869391345059102720
collection WordPress RSS
FRELIP Feed Integration
container_title Molecular Biomedicine
description
discipline_display Biology
discipline_facet Biology
format Online Article
RSS Article
genre Journal Article
id rss_article:97299
institution FRELIP
journal_source_facet Molecular Biomedicine
last_indexed 2026-06-30T03:35:12.778Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy
Biology
General
Biology
sub_discipline_display General
sub_discipline_facet General
subject_display Biology
General
Biology
subject_facet Biology
General
Biology
title Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy
title_alt El receptor de la hormona liberadora de prolactina (PRLHR) mejora la radiosensibilidad y exacerba el daño del ADN en glioblastoma post-irradiación al inhibir la translocación nuclear de la proteína 1 de unión a Y-box (YBX1): una nueva perspectiva sobre radioterapia de precisión
Le récepteur de l'hormone de libération de la prolactine (PRLHR) augmente la radiosensibilité et exacerbe les dommages à l'ADN dans le glioblastome post-irradiation en inhibant la translocation nucléaire de la protéine Y-box-binding-1 (YBX1) : une nouvelle perspective sur la radiothérapie de précision
O Receptor do Hormônio Liberador de Prolactina (PRLHR) aumenta a radiossensibilidade e exacerba o dano ao DNA em glioblastoma pós-irradiação ao inibir a translocação nuclear da proteína Y-box-binding-1 (YBX1): uma nova perspectiva sobre radioterapia de precisão
title_auth Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy
title_es_txt El receptor de la hormona liberadora de prolactina (PRLHR) mejora la radiosensibilidad y exacerba el daño del ADN en glioblastoma post-irradiación al inhibir la translocación nuclear de la proteína 1 de unión a Y-box (YBX1): una nueva perspectiva sobre radioterapia de precisión
title_fr_txt Le récepteur de l'hormone de libération de la prolactine (PRLHR) augmente la radiosensibilité et exacerbe les dommages à l'ADN dans le glioblastome post-irradiation en inhibant la translocation nucléaire de la protéine Y-box-binding-1 (YBX1) : une nouvelle perspective sur la radiothérapie de précision
title_full Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy
title_fullStr Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy
title_full_unstemmed Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy
title_pt_txt O Receptor do Hormônio Liberador de Prolactina (PRLHR) aumenta a radiossensibilidade e exacerba o dano ao DNA em glioblastoma pós-irradiação ao inibir a translocação nuclear da proteína Y-box-binding-1 (YBX1): uma nova perspectiva sobre radioterapia de precisão
title_short Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy
title_sort prolactin-releasing hormone receptor (prlhr) enhances radiosensitivity and exacerbates dna damage in glioblastoma post-irradiation by inhibiting y-box-binding protein-1 (ybx1) nuclear translocation: a novel perspective on precision radiotherapy
topic Biology
General
Biology
url https://link.springer.com/article/10.1186/s43556-026-00503-7